Site Group Page (References Reporting High Throughput Detection Method)
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Site Group Page (References Reporting High Throughput Detection Method)
 

Site Information
RPS3 (human) T221-p KDEILPTtPISEQKG 2, 6, 7, 11, 12, 13, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 56, 57, 58, 59, 60, 61, 62, 64, 65, 67, 68, 69, 70, 71, 72, 73, 76, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 100, 101, 103, 104, 105, 106, 107, 109, 110, 111, 112, 113, 116, 117, 118, 119, 120, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148
RPS3 (mouse) T221-p KDEILPTtPISEQKG 1, 3, 4, 5, 7, 8, 10, 14, 15, 54, 55, 63, 66, 74, 75, 77, 94, 95, 96, 97, 98, 99, 102, 108, 114, 115, 121, 122, 123, 124
RPS3 (rat) T221-p KDEILPTtPISEQKG 9

References

1

Wilson-Grady JT, Haas W, Gygi SP (2013) Quantitative comparison of the fasted and re-fed mouse liver phosphoproteomes using lower pH reductive dimethylation. Methods 61, 277-86
23567750   Curated Info

2

Zhou H, et al. (2013) Toward a comprehensive characterization of a human cancer cell phosphoproteome. J Proteome Res 12, 260-71
23186163   Curated Info

3

Wu X, et al. (2012) Investigation of receptor interacting protein (RIP3)-dependent protein phosphorylation by quantitative phosphoproteomics. Mol Cell Proteomics 11, 1640-51
22942356   Curated Info

4

Trost M, et al. (2012) Posttranslational regulation of self-renewal capacity: insights from proteome and phosphoproteome analyses of stem cell leukemia. Blood 120, e17-27
22802335   Curated Info

5

Goswami T, et al. (2012) Comparative phosphoproteomic analysis of neonatal and adult murine brain. Proteomics 12, 2185-9
22807455   Curated Info

6

Franz-Wachtel M, et al. (2012) Global detection of protein kinase D-dependent phosphorylation events in nocodazole-treated human cells. Mol Cell Proteomics 11, 160-70
22496350   Curated Info

7

Hsu PP, et al. (2011) The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 332, 1317-22
21659604   Curated Info

8

Yu Y, et al. (2011) Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science 332, 1322-6
21659605   Curated Info

9

Feric M, et al. (2011) Large-scale phosphoproteomic analysis of membrane proteins in renal proximal and distal tubule. Am J Physiol Cell Physiol 300, C755-70
21209370   Curated Info

10

Manes NP, et al. (2011) Discovery of mouse spleen signaling responses to anthrax using label-free quantitative phosphoproteomics via mass spectrometry. Mol Cell Proteomics 10, M110.000927
21189417   Curated Info

11

(2011) CST Curation Set: 11288; Year: 2011; SILAC: N; Biosample/Treatment: Jurkat(cell line)/calyculin & pervanadate; Disease: T cell leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-Thr-Pro Motif Antibody (polyAB) Cat#: 3003, PTMScan(R) Phospho-Thr-Pro Motif (T*P) Immunoaffinity Beads Cat#: 1996
Curated Info

12

Rigbolt KT, et al. (2011) System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation. Sci Signal 4, rs3
21406692   Curated Info

13

Kettenbach AN, et al. (2011) Quantitative phosphoproteomics identifies substrates and functional modules of aurora and polo-like kinase activities in mitotic cells. Sci Signal 4, rs5
21712546   Curated Info

14

Carlson SM, et al. (2011) Large-Scale Discovery of ERK2 Substrates Identifies ERK-Mediated Transcriptional Regulation by ETV3. Sci Signal 4, rs11
22028470   Curated Info

15

Huttlin EL, et al. (2010) A tissue-specific atlas of mouse protein phosphorylation and expression. Cell 143, 1174-89
21183079   Curated Info

16

Wang YT, et al. (2010) An informatics-assisted label-free quantitation strategy that depicts phosphoproteomic profiles in lung cancer cell invasion. J Proteome Res 9, 5582-97
20815410   Curated Info

17

Iliuk AB, et al. (2010) In-depth analyses of kinase-dependent tyrosine phosphoproteomes based on metal ion-functionalized soluble nanopolymers. Mol Cell Proteomics 9, 2162-72
20562096   Curated Info

18

(2010) CST Curation Set: 10300; Year: 2010; SILAC: N; Biosample/Treatment: Jurkat(cell line)/pervanadate & calyculin; Disease: T cell leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-Thr-Pro Motif Antibody (polyAB) Cat#: 3003, PTMScan(R) Phospho-Thr-Pro Motif (T*P) Immunoaffinity Beads Cat#: 1996
Curated Info

19

(2010) CST Curation Set: 10058; Year: 2010; SILAC: N; Biosample/Treatment: Jurkat(cell line)/pervanadate & calyculin; Disease: T cell leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

20

Christensen GL, et al. (2010) Quantitative phosphoproteomics dissection of seven-transmembrane receptor signaling using full and biased agonists. Mol Cell Proteomics 9, 1540-53
20363803   Curated Info

21

(2010) CST Curation Set: 9862; Year: 2010; SILAC: N; Biosample/Treatment: liver(tissue)/untreated; Disease: liver cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

22

(2010) CST Curation Set: 9865; Year: 2010; SILAC: N; Biosample/Treatment: liver(tissue)/untreated; Disease: liver cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

23

(2010) CST Curation Set: 9864; Year: 2010; SILAC: N; Biosample/Treatment: liver(tissue)/untreated; Disease: liver cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

24

(2010) CST Curation Set: 9867; Year: 2010; SILAC: N; Biosample/Treatment: liver(tissue)/untreated; Disease: liver cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

25

(2010) CST Curation Set: 9866; Year: 2010; SILAC: N; Biosample/Treatment: liver(tissue)/untreated; Disease: liver cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

26

(2010) CST Curation Set: 9870; Year: 2010; SILAC: N; Biosample/Treatment: liver(tissue)/untreated; Disease: liver cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

27

(2010) CST Curation Set: 9869; Year: 2010; SILAC: N; Biosample/Treatment: liver(tissue)/untreated; Disease: liver cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

28

(2010) CST Curation Set: 9861; Year: 2010; SILAC: N; Biosample/Treatment: liver(tissue)/untreated; Disease: liver cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

29

(2010) CST Curation Set: 9868; Year: 2010; SILAC: N; Biosample/Treatment: liver(tissue)/untreated; Disease: liver cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

30

Bennetzen MV, et al. (2010) Site-specific phosphorylation dynamics of the nuclear proteome during the DNA damage response. Mol Cell Proteomics 9, 1314-23
20164059   Curated Info

31

(2010) CST Curation Set: 9850; Year: 2010; SILAC: N; Biosample/Treatment: liver(tissue)/untreated; Disease: liver cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

32

(2010) CST Curation Set: 9834; Year: 2010; SILAC: N; Biosample/Treatment: liver(tissue)/untreated; Disease: liver cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

33

(2010) CST Curation Set: 9852; Year: 2010; SILAC: N; Biosample/Treatment: liver(tissue)/untreated; Disease: liver cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

34

(2010) CST Curation Set: 9824; Year: 2010; SILAC: N; Biosample/Treatment: liver(tissue)/untreated; Disease: liver cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

35

(2010) CST Curation Set: 9831; Year: 2010; SILAC: N; Biosample/Treatment: liver(tissue)/untreated; Disease: liver cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

36

(2010) CST Curation Set: 9835; Year: 2010; SILAC: N; Biosample/Treatment: liver(tissue)/untreated; Disease: liver cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

37

(2010) CST Curation Set: 9842; Year: 2010; SILAC: N; Biosample/Treatment: liver(tissue)/untreated; Disease: liver cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

38

(2010) CST Curation Set: 9832; Year: 2010; SILAC: N; Biosample/Treatment: liver(tissue)/untreated; Disease: liver cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

39

(2010) CST Curation Set: 9851; Year: 2010; SILAC: N; Biosample/Treatment: liver(tissue)/untreated; Disease: liver cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

40

(2010) CST Curation Set: 9843; Year: 2010; SILAC: N; Biosample/Treatment: liver(tissue)/untreated; Disease: liver cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

41

(2010) CST Curation Set: 9853; Year: 2010; SILAC: N; Biosample/Treatment: liver(tissue)/untreated; Disease: liver cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

42

(2010) CST Curation Set: 9845; Year: 2010; SILAC: N; Biosample/Treatment: liver(tissue)/untreated; Disease: liver cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

43

(2010) CST Curation Set: 9829; Year: 2010; SILAC: N; Biosample/Treatment: pancreas(tissue)/untreated; Disease: pancreatic cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

44

(2010) CST Curation Set: 9849; Year: 2010; SILAC: N; Biosample/Treatment: thyroid(tissue)/untreated; Disease: thyroid cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

45

(2010) CST Curation Set: 9838; Year: 2010; SILAC: N; Biosample/Treatment: liver(tissue)/untreated; Disease: liver cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

46

(2010) CST Curation Set: 9854; Year: 2010; SILAC: N; Biosample/Treatment: liver(tissue)/untreated; Disease: liver cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

47

(2010) CST Curation Set: 9839; Year: 2010; SILAC: N; Biosample/Treatment: liver(tissue)/untreated; Disease: liver cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

48

(2010) CST Curation Set: 9855; Year: 2010; SILAC: N; Biosample/Treatment: liver(tissue)/untreated; Disease: liver cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

49

(2010) CST Curation Set: 9836; Year: 2010; SILAC: N; Biosample/Treatment: liver(tissue)/untreated; Disease: liver cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

50

(2010) CST Curation Set: 9830; Year: 2010; SILAC: N; Biosample/Treatment: liver(tissue)/untreated; Disease: liver cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

51

(2010) CST Curation Set: 9840; Year: 2010; SILAC: N; Biosample/Treatment: liver(tissue)/untreated; Disease: liver cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

52

(2010) CST Curation Set: 9844; Year: 2010; SILAC: N; Biosample/Treatment: liver(tissue)/untreated; Disease: liver cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

53

Schreiber TB, et al. (2010) An integrated phosphoproteomics work flow reveals extensive network regulation in early lysophosphatidic acid signaling. Mol Cell Proteomics 9, 1047-62
20071362   Curated Info

54

Weintz G, et al. (2010) The phosphoproteome of toll-like receptor-activated macrophages. Mol Syst Biol 6, 371
20531401   Curated Info

55

Wiśniewski JR, et al. (2010) Brain phosphoproteome obtained by a FASP-based method reveals plasma membrane protein topology. J Proteome Res 9, 3280-9
20415495   Curated Info

56

(2010) CST Curation Set: 9779; Year: 2010; SILAC: N; Biosample/Treatment: skin(tissue)/untreated; Disease: melanoma skin cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

57

(2010) CST Curation Set: 9777; Year: 2010; SILAC: N; Biosample/Treatment: skin(tissue)/untreated; Disease: melanoma skin cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

58

(2010) CST Curation Set: 9782; Year: 2010; SILAC: N; Biosample/Treatment: skin(tissue)/untreated; Disease: melanoma skin cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

59

(2010) CST Curation Set: 9784; Year: 2010; SILAC: N; Biosample/Treatment: skin(tissue)/untreated; Disease: melanoma skin cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

60

(2010) CST Curation Set: 9780; Year: 2010; SILAC: N; Biosample/Treatment: skin(tissue)/untreated; Disease: melanoma skin cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

61

(2010) CST Curation Set: 9786; Year: 2010; SILAC: N; Biosample/Treatment: skin(tissue)/untreated; Disease: melanoma skin cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

62

(2010) CST Curation Set: 9781; Year: 2010; SILAC: N; Biosample/Treatment: skin(tissue)/untreated; Disease: melanoma skin cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

63

(2010) CST Curation Set: 9739; Year: 2010; SILAC: N; Biosample/Treatment: liver(tissue)/control; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(K/R)XX(s/t)(phosphorylation)
Curated Info

64

Ge F, et al. (2010) Phosphoproteomic analysis of primary human multiple myeloma cells. J Proteomics 73, 1381-90
20230923   Curated Info

65

(2010) CST Curation Set: 9441; Year: 2010; SILAC: N; Biosample/Treatment: Jurkat(cell line)/pervanadate & calyculin; Disease: T cell leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-Thr-Pro Motif Antibody (polyAB) Cat#: 3003, PTMScan(R) Phospho-Thr-Pro Motif (T*P) Immunoaffinity Beads Cat#: 1996
Curated Info

66

Rinschen MM, et al. (2010) Quantitative phosphoproteomic analysis reveals vasopressin V2-receptor-dependent signaling pathways in renal collecting duct cells. Proc Natl Acad Sci U S A 107, 3882-7
20139300   Curated Info

67

(2010) CST Curation Set: 8993; Year: 2010; SILAC: N; Biosample/Treatment: Jurkat(cell line)/pervanadate & calyculin; Disease: T cell leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-Thr-Pro Motif Antibody (polyAB) Cat#: 3003, PTMScan(R) Phospho-Thr-Pro Motif (T*P) Immunoaffinity Beads Cat#: 1996
Curated Info

68

(2010) CST Curation Set: 8990; Year: 2010; SILAC: N; Biosample/Treatment: Jurkat(cell line)/pervanadate & calyculin; Disease: T cell leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

69

(2010) CST Curation Set: 8974; Year: 2010; SILAC: N; Biosample/Treatment: Jurkat(cell line)/pervanadate & calyculin; Disease: T cell leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-Thr-Pro Motif Antibody (polyAB) Cat#: 3003, PTMScan(R) Phospho-Thr-Pro Motif (T*P) Immunoaffinity Beads Cat#: 1996
Curated Info

70

(2010) CST Curation Set: 8985; Year: 2010; SILAC: N; Biosample/Treatment: Jurkat(cell line)/pervanadate & calyculin; Disease: T cell leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-Thr-Pro Motif Antibody (polyAB) Cat#: 3003, PTMScan(R) Phospho-Thr-Pro Motif (T*P) Immunoaffinity Beads Cat#: 1996
Curated Info

71

Raijmakers R, et al. (2010) Exploring the human leukocyte phosphoproteome using a microfluidic reversed-phase-TiO2-reversed-phase high-performance liquid chromatography phosphochip coupled to a quadrupole time-of-flight mass spectrometer. Anal Chem 82, 824-32
20058876   Curated Info

72

(2010) CST Curation Set: 9056; Year: 2010; SILAC: N; Biosample/Treatment: HeLa(cell line)/untreated; Disease: cervical adenocarcinoma; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

73

Olsen JV, et al. (2010) Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal 3, ra3
20068231   Curated Info

74

Tweedie-Cullen RY, Reck JM, Mansuy IM (2009) Comprehensive mapping of post-translational modifications on synaptic, nuclear, and histone proteins in the adult mouse brain. J Proteome Res 8, 4966-82
19737024   Curated Info

75

Choudhary C, et al. (2009) Mislocalized activation of oncogenic RTKs switches downstream signaling outcomes. Mol Cell 36, 326-39
19854140   Curated Info

76

Malik R, et al. (2009) Quantitative analysis of the human spindle phosphoproteome at distinct mitotic stages. J Proteome Res 8, 4553-63
19691289   Curated Info

77

Kim BG, et al. (2009) 'Two-stage double-technique hybrid (TSDTH)' identification strategy for the analysis of BMP2-induced transdifferentiation of premyoblast C2C12 cells to osteoblast. J Proteome Res 8, 4441-54
19655815   Curated Info

78

(2009) CST Curation Set: 7661; Year: 2009; SILAC: N; Biosample/Treatment: bone marrow(tissue)/untreated; Disease: acute myelogenous leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

79

(2009) CST Curation Set: 7662; Year: 2009; SILAC: N; Biosample/Treatment: bone marrow(tissue)/untreated; Disease: acute myelogenous leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

80

Van Hoof D, et al. (2009) Phosphorylation dynamics during early differentiation of human embryonic stem cells. Cell Stem Cell 5, 214-26
19664995   Curated Info

81

Brill LM, et al. (2009) Phosphoproteomic analysis of human embryonic stem cells. Cell Stem Cell 5, 204-13
19664994   Curated Info

82

Oppermann FS, et al. (2009) Large-scale proteomics analysis of the human kinome. Mol Cell Proteomics 8, 1751-64
19369195   Curated Info

83

(2009) CST Curation Set: 6995; Year: 2009; SILAC: N; Biosample/Treatment: K562(cell line)/-; Disease: chronic myelogenous leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

84

(2009) CST Curation Set: 6994; Year: 2009; SILAC: N; Biosample/Treatment: K562(cell line)/-; Disease: chronic myelogenous leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

85

(2009) CST Curation Set: 6983; Year: 2009; SILAC: N; Biosample/Treatment: Molm 14(cell line)/-; Disease: acute myelogenous leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

86

(2009) CST Curation Set: 6982; Year: 2009; SILAC: N; Biosample/Treatment: Molm 14(cell line)/-; Disease: acute myelogenous leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

87

(2009) CST Curation Set: 6989; Year: 2009; SILAC: N; Biosample/Treatment: SEM(cell line)/-; Disease: acute lymphocytic leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

88

(2009) CST Curation Set: 6988; Year: 2009; SILAC: N; Biosample/Treatment: SEM(cell line)/-; Disease: acute lymphocytic leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

89

(2009) CST Curation Set: 6851; Year: 2009; SILAC: N; Biosample/Treatment: Jurkat(cell line)/pervanadate & calyculin; Disease: T cell leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation)
Curated Info

90

Nagano K, et al. (2009) Phosphoproteomic analysis of distinct tumor cell lines in response to nocodazole treatment. Proteomics 9, 2861-74
19415658   Curated Info

91

(2009) CST Curation Set: 6253; Year: 2009; SILAC: N; Biosample/Treatment: HeLa(cell line)/UV; Disease: cervical adenocarcinoma; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

92

Joughin BA, et al. (2009) An integrated comparative phosphoproteomic and bioinformatic approach reveals a novel class of MPM-2 motifs upregulated in EGFRvIII-expressing glioblastoma cells. Mol Biosyst 5, 59-67
19081932   Curated Info

93

Mayya V, et al. (2009) Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci Signal 2, ra46
19690332   Curated Info

94

Zanivan S, et al. (2008) Solid tumor proteome and phosphoproteome analysis by high resolution mass spectrometry. J Proteome Res 7, 5314-26
19367708   Curated Info

95

(2008) CST Curation Set: 5597; Year: 2008; SILAC: N; Biosample/Treatment: 10T1/2FGFRK668E(cell line)/FGF; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

96

(2008) CST Curation Set: 5596; Year: 2008; SILAC: N; Biosample/Treatment: 10T1/2FGFRK668E(cell line)/FGF; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

97

(2008) CST Curation Set: 5594; Year: 2008; SILAC: N; Biosample/Treatment: 10T1/2FGFRK668E(cell line)/control; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

98

(2008) CST Curation Set: 5595; Year: 2008; SILAC: N; Biosample/Treatment: 10T1/2FGFRK668E(cell line)/FGF; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

99

Pan C, Gnad F, Olsen JV, Mann M (2008) Quantitative phosphoproteome analysis of a mouse liver cell line reveals specificity of phosphatase inhibitors. Proteomics 8, 4534-46
18846507   Curated Info

100

Chi Y, et al. (2008) Identification of CDK2 substrates in human cell lysates. Genome Biol 9, R149
18847512   Curated Info

101

Tsai CF, et al. (2008) Immobilized metal affinity chromatography revisited: pH/acid control toward high selectivity in phosphoproteomics. J Proteome Res 7, 4058-69
18707149   Curated Info

102

Wang Z, Gucek M, Hart GW (2008) Cross-talk between GlcNAcylation and phosphorylation: site-specific phosphorylation dynamics in response to globally elevated O-GlcNAc. Proc Natl Acad Sci U S A 105, 13793-8
18779572   Curated Info

103

Daub H, et al. (2008) Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. Mol Cell 31, 438-48
18691976   Curated Info

104

Dephoure N, et al. (2008) A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A 105, 10762-7
18669648   Curated Info

105

Thingholm TE, et al. (2008) TiO2-Based Phosphoproteomic Analysis of the Plasma Membrane and the Effects of Phosphatase Inhibitor Treatment. J Proteome Res 7, 3304-3313
18578522   Curated Info

106

(2008) CST Curation Set: 4391; Year: 2008; SILAC: N; Biosample/Treatment: K562(cell line)/untreated; Disease: chronic myelogenous leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-[sty](phosphorylation)
Curated Info

107

Sui S, et al. (2008) Phosphoproteome analysis of the human Chang liver cells using SCX and a complementary mass spectrometric strategy. Proteomics 8, 2024-34
18491316   Curated Info

108

Krüger M, et al. (2008) Dissection of the insulin signaling pathway via quantitative phosphoproteomics. Proc Natl Acad Sci U S A 105, 2451-6
18268350   Curated Info

109

(2008) CST Curation Set: 3884; Year: 2008; SILAC: N; Biosample/Treatment: Jurkat(cell line)/pervanadate; Disease: T cell leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-[sty](phosphorylation)
Curated Info

110

Imami K, et al. (2008) Automated Phosphoproteome Analysis for Cultured Cancer Cells by Two-Dimensional NanoLC-MS Using a Calcined Titania/C18 Biphasic Column. Anal Sci 24, 161-6
18187866   Curated Info

111

(2007) CST Curation Set: 3480; Year: 2007; SILAC: N; Biosample/Treatment: Jurkat(cell line)/pervanadate & calyculin; Disease: T cell leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Millipore 05-368
Curated Info

112

(2007) CST Curation Set: 3481; Year: 2007; SILAC: N; Biosample/Treatment: Jurkat(cell line)/pervanadate & calyculin; Disease: T cell leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-(s/t)P(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-Thr-Pro Motif Antibody (polyAB) Cat#: 3003, PTMScan(R) Phospho-Thr-Pro Motif (T*P) Immunoaffinity Beads Cat#: 1996
Curated Info

113

(2007) CST Curation Set: 3471; Year: 2007; SILAC: N; Biosample/Treatment: ovary(tissue)/untreated; Disease: ovarian cancer; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-pTyr Antibody Used to Purify Peptides prior to MS2: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991
Curated Info

114

(2007) CST Curation Set: 3381; Year: 2007; SILAC: N; Biosample/Treatment: Mouse Mesenchymal Stem Cells(cell line)/untreated; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXsP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK/CDK Substrates (PXSP or SPXR/K) (34B2) Rabbit mAb Cat#: 2325, PTMScan(R) Phospho-MAPK/CDK Substrate Motif (PXS*P, S*PXK/R) Immunoaffinity Beads Cat#: 1982
Curated Info

115

(2007) CST Curation Set: 3382; Year: 2007; SILAC: N; Biosample/Treatment: Mouse Mesenchymal Stem Cells(cell line)/bFGF; Disease: -; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXsP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK/CDK Substrates (PXSP or SPXR/K) (34B2) Rabbit mAb Cat#: 2325, PTMScan(R) Phospho-MAPK/CDK Substrate Motif (PXS*P, S*PXK/R) Immunoaffinity Beads Cat#: 1982
Curated Info

116

(2007) CST Curation Set: 2608; Year: 2007; SILAC: N; Biosample/Treatment: bone marrow(tissue)/untreated; Disease: acute myelogenous leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

117

(2007) CST Curation Set: 2613; Year: 2007; SILAC: N; Biosample/Treatment: bone marrow(tissue)/untreated; Disease: acute myelogenous leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

118

(2007) CST Curation Set: 2590; Year: 2007; SILAC: N; Biosample/Treatment: bone marrow(tissue)/-; Disease: acute myelogenous leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

119

(2007) CST Curation Set: 2591; Year: 2007; SILAC: N; Biosample/Treatment: bone marrow(tissue)/-; Disease: acute myelogenous leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

120

Molina H, et al. (2007) Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry. Proc Natl Acad Sci U S A 104, 2199-204
17287340   Curated Info

121

Munton RP, et al. (2007) Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations. Mol Cell Proteomics 6, 283-93
17114649   Curated Info

122

Villén J, Beausoleil SA, Gerber SA, Gygi SP (2007) Large-scale phosphorylation analysis of mouse liver. Proc Natl Acad Sci U S A 104, 1488-93
17242355   Curated Info

123

Dai J, et al. (2007) Protein phosphorylation and expression profiling by Yin-yang multidimensional liquid chromatography (Yin-yang MDLC) mass spectrometry. J Proteome Res 6, 250-62
17203969   Curated Info

124

Puente LG, Voisin S, Lee RE, Megeney LA (2006) Reconstructing the regulatory kinase pathways of myogenesis from phosphopeptide data. Mol Cell Proteomics 5, 2244-51
16971385   Curated Info

125

(2006) CST Curation Set: 1923; Year: 2006; SILAC: N; Biosample/Treatment: Molm 14(cell line)/Flt3 inhibitor; Disease: acute myelogenous leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

126

(2006) CST Curation Set: 1925; Year: 2006; SILAC: N; Biosample/Treatment: Molm 14(cell line)/-; Disease: acute myelogenous leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

127

(2006) CST Curation Set: 1896; Year: 2006; SILAC: N; Biosample/Treatment: MV4-11(cell line)/Flt3 inhibitor; Disease: acute myelogenous leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

128

(2006) CST Curation Set: 1898; Year: 2006; SILAC: N; Biosample/Treatment: MV4-11(cell line)/-; Disease: acute myelogenous leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

129

Beausoleil SA, et al. (2006) A probability-based approach for high-throughput protein phosphorylation analysis and site localization. Nat Biotechnol 24, 1285-92
16964243   Curated Info

130

(2006) CST Curation Set: 1834; Year: 2006; SILAC: N; Biosample/Treatment: SEM(cell line)/Flt3 inhibitor; Disease: acute lymphocytic leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

131

(2006) CST Curation Set: 1836; Year: 2006; SILAC: N; Biosample/Treatment: SEM(cell line)/-; Disease: acute lymphocytic leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

132

(2006) CST Curation Set: 1824; Year: 2006; SILAC: N; Biosample/Treatment: SEM(cell line)/Flt3 inhibitor; Disease: acute lymphocytic leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

133

(2006) CST Curation Set: 1826; Year: 2006; SILAC: N; Biosample/Treatment: SEM(cell line)/-; Disease: acute lymphocytic leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

134

(2006) CST Curation Set: 1785; Year: 2006; SILAC: N; Biosample/Treatment: HEL(cell line)/Flt3 inhibitor; Disease: erythroid leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

135

(2006) CST Curation Set: 1787; Year: 2006; SILAC: N; Biosample/Treatment: HEL(cell line)/-; Disease: erythroid leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

136

Nousiainen M, et al. (2006) Phosphoproteome analysis of the human mitotic spindle. Proc Natl Acad Sci U S A 103, 5391-6
16565220   Curated Info

137

(2005) CST Curation Set: 658; Year: 2005; SILAC: N; Biosample/Treatment: HT-29(cell line)/-; Disease: colorectal carcinoma; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

138

(2005) CST Curation Set: 659; Year: 2005; SILAC: N; Biosample/Treatment: HT-29(cell line)/-; Disease: colorectal carcinoma; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

139

(2005) CST Curation Set: 800; Year: 2005; SILAC: N; Biosample/Treatment: HT-29(cell line)/-; Disease: colorectal carcinoma; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

140

(2005) CST Curation Set: 660; Year: 2005; SILAC: N; Biosample/Treatment: HT-29(cell line)/-; Disease: colorectal carcinoma; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

141

(2005) CST Curation Set: 661; Year: 2005; SILAC: N; Biosample/Treatment: HT-29(cell line)/-; Disease: colorectal carcinoma; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

142

(2005) CST Curation Set: 591; Year: 2005; SILAC: N; Biosample/Treatment: K562(cell line)/-; Disease: chronic myelogenous leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

143

(2005) CST Curation Set: 592; Year: 2005; SILAC: N; Biosample/Treatment: K562(cell line)/-; Disease: chronic myelogenous leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

144

(2005) CST Curation Set: 594; Year: 2005; SILAC: N; Biosample/Treatment: K562(cell line)/-; Disease: chronic myelogenous leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

145

(2005) CST Curation Set: 593; Year: 2005; SILAC: N; Biosample/Treatment: K562(cell line)/-; Disease: chronic myelogenous leukemia; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

146

Ficarro SB, et al. (2005) Automated immobilized metal affinity chromatography/nano-liquid chromatography/electrospray ionization mass spectrometry platform for profiling protein phosphorylation sites. Rapid Commun Mass Spectrom 19, 57-71
15570572   Curated Info

147

Beausoleil SA, et al. (2004) Large-scale characterization of HeLa cell nuclear phosphoproteins. Proc Natl Acad Sci U S A 101, 12130-5
15302935   Curated Info

148

(2004) CST Curation Set: 274; Year: 2004; SILAC: N; Biosample/Treatment: HeLa(cell line)/nocodazole; Disease: cervical adenocarcinoma; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-PXtP(phosphorylation) Antibody Used to Purify Peptides prior to MS2: Phospho-MAPK Substrates (PXTP) (46G11) Rabbit mAb Cat#: 4391, PTMScan(R) Phospho-MAPK Substrate Motif (PXpTP) Immunoaffinity Beads Cat#: 1983
Curated Info

Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.